| Cas No.: | 171228-49-2 |
| 名称: | 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)-tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2-((2S,3S)-2-hydroxypentan-3-yl)-2H-1,2,4-triazol-3(4H)-one |
| 别名: | Noxafil |
| SMILES: | N1=CN(C2=CC=C(N3CCN(C4=CC=C(OC[C@@H]5C[C@@](CN6C=NC=N6)(C6=CC=C(F)C=C6F)OC5)C=C4)CC3)C=C2)C(=O)N1[C@H](CC)[C@H](O)C |
| 分子式: | C37H42F2N8O4 |
| 分子量: | 700.78 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | For the detailed information of Posaconazole, the solubility of Posaconazole in water, the solubility of Posaconazole in DMSO, the solubility of Posaconazole in PBS buffer, the animal experiment（test） (test) of Posaconazole, the cell expriment (test) of Posaconazole, the in vivo, in vitro and clinical trial test of Posaconazole, the EC50, IC50,and Affinity of Posaconazole,, please contact DC Chemicals. |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |
MSDS
| TITLE | DOWNLOAD |
| MSDS_2950_DCAPI1093_171228-49-2 |
|
COA
| LOT NO. | DOWNLOAD |
|
|
